pf-04427429
mAbexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2009 (NCT01011296)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pf-04427429
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01511497 | Phase 1 | Oct 1, 2011 | Pfizer |
| NCT01147432 | Phase 1 | Aug 1, 2010 | Pfizer |
| NCT01165723 | Phase 1 | Aug 1, 2010 | Pfizer |
| NCT01117233 | Phase 1 | May 1, 2010 | Pfizer |
| NCT01011296 | Phase 1 | Dec 1, 2009 | Pfizer |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 5 | 5 | 1 | 2009 |
1 organizations
Page 1 / 1